Asher Khan

587 total citations
12 papers, 427 citations indexed

About

Asher Khan is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Asher Khan has authored 12 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Asher Khan's work include Traumatic Brain Injury and Neurovascular Disturbances (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Neonatal and fetal brain pathology (2 papers). Asher Khan is often cited by papers focused on Traumatic Brain Injury and Neurovascular Disturbances (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Neonatal and fetal brain pathology (2 papers). Asher Khan collaborates with scholars based in United States, Australia and Bahrain. Asher Khan's co-authors include Casey Burton, Sudhanshu P. Raikwar, Smita Zaheer, Govindhasamy Pushpavathi Selvakumar, Shankar S. Iyer, Ramasamy Thangavel, Asgar Zaheer, Donald James, Duraisamy Kempuraj and Mohammad Ejaz Ahmed and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Experimental Neurology.

In The Last Decade

Asher Khan

11 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Asher Khan United States	6	175	161	94	59	51	12	427
Kiandokht Keyhanian United States	11	81 0.5×	199 1.2×	61 0.6×	34 0.6×	47 0.9×	19	398
Itxaso Martì Spain	8	125 0.7×	344 2.1×	55 0.6×	119 2.0×	35 0.7×	20	534
Marcus Vinícius Magno Gonçalves Brazil	13	93 0.5×	125 0.8×	30 0.3×	23 0.4×	24 0.5×	54	469
Gustavo Adolfo Argañaraz Brazil	12	139 0.8×	96 0.6×	193 2.1×	31 0.5×	32 0.6×	25	560
Saskia Räuber Germany	8	63 0.4×	129 0.8×	51 0.5×	40 0.7×	60 1.2×	25	275
Carmela Romano Italy	10	127 0.7×	82 0.5×	54 0.6×	34 0.6×	38 0.7×	16	366
James Galea United Kingdom	8	150 0.9×	133 0.8×	50 0.5×	55 0.9×	161 3.2×	9	449
Jamie Greenfield Canada	10	94 0.5×	88 0.5×	28 0.3×	32 0.5×	90 1.8×	20	459
Jeffrey O’Callaghan Ireland	9	123 0.7×	118 0.7×	45 0.5×	12 0.2×	78 1.5×	16	406
Raha Dastgheyb United States	13	291 1.7×	54 0.3×	83 0.9×	28 0.5×	107 2.1×	48	565

Countries citing papers authored by Asher Khan

Since Specialization

Citations

This map shows the geographic impact of Asher Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asher Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asher Khan more than expected).

Fields of papers citing papers by Asher Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asher Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asher Khan. The network helps show where Asher Khan may publish in the future.

Co-authorship network of co-authors of Asher Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Asher Khan. A scholar is included among the top collaborators of Asher Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asher Khan. Asher Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Khan, Asher, et al.. (2024). Global Disparities in Access to Vaccine Clinical Trials: A Review of the Literature. Vaccines. 12(4). 348–348. 5 indexed citations

Khan, Asher, et al.. (2023). Dry eye in the upper blepharoplasty patient: a study comparing orbicularis-sparing versus orbicularis-excising techniques. Graefe s Archive for Clinical and Experimental Ophthalmology. 261(12). 3625–3634. 1 indexed citations

Khan, Asher, et al.. (2023). Malignant Melanoma Presenting as Spinal Cord and Pleural Lesions. SHILAP Revista de lepidopterología. 2023. 1–6. 2 indexed citations

Carr, Thomas H., et al.. (2022). Repeated mild traumatic brain injuries in mice cause age- and sex-specific alterations in dendritic spine density. Experimental Neurology. 357. 114172–114172. 11 indexed citations

Khan, Asher, et al.. (2021). Impact of COVID-19 Pandemic on Cancer Screening in the United States. 17(1). 3–4. 1 indexed citations

Ahmed, Mohammad Ejaz, Govindhasamy Pushpavathi Selvakumar, Duraisamy Kempuraj, et al.. (2020). Glia Maturation Factor (GMF) Regulates Microglial Expression Phenotypes and the Associated Neurological Deficits in a Mouse Model of Traumatic Brain Injury. Molecular Neurobiology. 57(11). 4438–4450. 12 indexed citations

Khan, Asher, et al.. (2020). Microglia dynamics in adolescent traumatic brain injury. Journal of Neuroinflammation. 17(1). 326–326. 29 indexed citations

Kempuraj, Duraisamy, Govindhasamy Pushpavathi Selvakumar, Mohammad Ejaz Ahmed, et al.. (2020). COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation. The Neuroscientist. 26(5-6). 402–414. 215 indexed citations

Selvakumar, Govindhasamy Pushpavathi, Mohammad Ejaz Ahmed, Shankar S. Iyer, et al.. (2020). Absence of Glia Maturation Factor Protects from Axonal Injury and Motor Behavioral Impairments after Traumatic Brain Injury. Experimental Neurobiology. 29(3). 230–248. 14 indexed citations

10.

Kapur, Suman, et al.. (2017). A Study of Genetic Markers in Patients of Rheumatoid Arthritis and their Co-Relation with Severity of the Disease.. PubMed. 65(9). 32–36. 3 indexed citations

11.

Wang, Xin, Magdalena Mazurkiewicz, Ellin‐Kristina Hillert, et al.. (2016). The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells. Scientific Reports. 6(1). 26979–26979. 133 indexed citations

12.

Reece, Donna, et al.. (2009). A333 Phase I/II Trial of Cyclophosphamide, Prednisone, and Lenalidomide for Relapsed and Refractory MM. Clinical Lymphoma & Myeloma. 9. S53–S53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact